Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics is a company that uses its protein engineering capabilities to create multifunctional precision immunotherapies for the treatment of cancer.
Funding history
About Bright Peak Therapeutics, Inc.
How much funding has Bright Peak Therapeutics, Inc. raised?
Bright Peak Therapeutics, Inc. has raised $90.0M in total funding. The most recent round was Series C.
Where is Bright Peak Therapeutics, Inc. headquartered?
Bright Peak Therapeutics, Inc. is headquartered in Del Mar, CA.
What does Bright Peak Therapeutics, Inc. do?
Bright Peak Therapeutics is a company that uses its protein engineering capabilities to create multifunctional precision immunotherapies for the treatment of cancer.
What's Bright Peak Therapeutics, Inc.'s solution?
Bright Peak uses proprietary protein engineering to develop next-generation multifunctional precision immunotherapies for treating cancer.
What makes Bright Peak Therapeutics, Inc. different?
The site claims 'world-class' proprietary protein engineering capabilities used to design multifunctional biologics through chemistry.
What makes Bright Peak Therapeutics, Inc. notable?
Bright Peak Therapeutics was founded in 2017 by Vijaya Pattabiraman and Jeffrey Bode and raised a $90M Series C backed by Versant Ventures, Fidelity, RA Capital, and the Qatar Investment Authority.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
